These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11395897)

  • 1. Anticoagulation in continuous renal replacement therapy.
    Schetz M
    Contrib Nephrol; 2001; (132):283-303. PubMed ID: 11395897
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation.
    Morabito S; Pistolesi V; Tritapepe L; Vitaliano E; Zeppilli L; Polistena F; Fiaccadori E; Pierucci A
    Int J Artif Organs; 2013 Dec; 36(12):845-52. PubMed ID: 24362894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous Renal Replacement Therapy and Anticoagulation: What Are the Options?
    Dirkes S; Wonnacott R
    Crit Care Nurse; 2016 Apr; 36(2):34-41. PubMed ID: 27037337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical aspects of renal replacement therapy.
    Kox WJ; Rohr U; Wauer H
    Int J Artif Organs; 1996 Feb; 19(2):100-5. PubMed ID: 8647602
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation, Fibrinolysis and Inhibitors in Failing Filters during Continuous Venovenous Hemofiltration in Critically Ill Patients with Acute Kidney Injury: Effect of Anticoagulation Modalities.
    Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
    Blood Purif; 2015; 39(4):297-305. PubMed ID: 25966765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits of citrate anticoagulation for continuous renal replacement therapy.
    Shum HP; Yan WW; Chan TM
    Hong Kong Med J; 2015 Apr; 21(2):149-54. PubMed ID: 25477338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP; Fernández Sarmiento J; Rojas Velasquez AM; González Chaparro LS; Gastelbondo Amaya R; Mulett Hoyos H; Tibaduiza D; Quintero Gómez AM
    Pediatr Nephrol; 2017 Apr; 32(4):703-711. PubMed ID: 27896442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF).
    Hofmann RM; Maloney C; Ward DM; Becker BN
    Ren Fail; 2002 May; 24(3):325-35. PubMed ID: 12166699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation in COVID-19 patients requiring continuous renal replacement therapy.
    Attallah N; Gupta S; Madhyastha R; El Nekidy WS; Mallat J
    Anaesth Crit Care Pain Med; 2021 Jun; 40(3):100841. PubMed ID: 33746074
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemofiltration in children.
    Saborio P; Hahn S; Scheinman JI; Chan JC
    Int J Artif Organs; 1998 Jul; 21(7):371-7. PubMed ID: 9745990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute renal failure - anticoagulation in continuous renal replacement therapy].
    Hein OV; Birnbaum J; Spies C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):294-301; quiz 302. PubMed ID: 18409124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of anticoagulation regimens on handling of interleukin-6 and -8 during continuous venovenous hemofiltration in critically ill patients with acute kidney injury.
    Schilder L; Nurmohamed SA; ter Wee PM; Girbes AR; Beishuizen A; Paauw NJ; Beelen RH; Groeneveld AB
    Cytokine; 2012 Dec; 60(3):601-7. PubMed ID: 23006672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.
    Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
    Crit Care; 2015 Nov; 19():392. PubMed ID: 26573621
    [No Abstract]   [Full Text] [Related]  

  • 14. White clot syndrome and continuous arteriovenous haemofiltration.
    Shelly MP; Majer RV; Perkins C; Pierce T; Nielsen MS
    Intensive Care Med; 1990; 16(5):334-5. PubMed ID: 2212262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative?
    Tolwani A; Wille KM
    Am J Kidney Dis; 2012 Jun; 59(6):745-7. PubMed ID: 22613393
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphate balance with continuous renal replacement therapy: a simple solution.
    Hiremath S; Slivar S; Magner P
    Am J Kidney Dis; 2013 Sep; 62(3):644. PubMed ID: 23972063
    [No Abstract]   [Full Text] [Related]  

  • 17. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
    Davenport A
    Contrib Nephrol; 2004; 144():317-28. PubMed ID: 15264420
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent hirudin versus continuous heparin for anticoagulation in continuous renal replacement therapy.
    Hein OV; von Heymann C; Diehl T; Ziemer S; Ronco C; Morgera S; Siebert G; Kox WJ; Neumayer HH; Spies C
    Ren Fail; 2004 May; 26(3):297-303. PubMed ID: 15354980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional citrate anticoagulation for continuous arteriovenous hemodialysis. An update after 12 months.
    Mehta RL; McDonald BR; Ward DM
    Contrib Nephrol; 1991; 93():210-4. PubMed ID: 1802583
    [No Abstract]   [Full Text] [Related]  

  • 20. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.